Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

154 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?
Askling J, van Vollenhoven RF, Granath F, Raaschou P, Fored CM, Baecklund E, Dackhammar C, Feltelius N, Cöster L, Geborek P, Jacobsson LT, Lindblad S, Rantapää-Dahlqvist S, Saxne T, Klareskog L. Askling J, et al. Among authors: geborek p. Arthritis Rheum. 2009 Nov;60(11):3180-9. doi: 10.1002/art.24941. Arthritis Rheum. 2009. PMID: 19877027
Effectiveness and Feasibility Associated with Switching to a Second or Third TNF Inhibitor in Patients with Psoriatic Arthritis: A Cohort Study from Southern Sweden.
Kristensen LE, Lie E, Jacobsson LT, Christensen R, Mease PJ, Bliddal H, Geborek P. Kristensen LE, et al. Among authors: geborek p. J Rheumatol. 2016 Jan;43(1):81-7. doi: 10.3899/jrheum.150744. Epub 2015 Dec 1. J Rheumatol. 2016. PMID: 26628604
Predictors of work disability during the first 3 years after diagnosis in a national rheumatoid arthritis inception cohort.
Olofsson T, Petersson IF, Eriksson JK, Englund M, Simard JF, Nilsson JÅ, Geborek P, Jacobsson LT, Askling J, Neovius M. Olofsson T, et al. Among authors: geborek p. Ann Rheum Dis. 2014 May;73(5):845-53. doi: 10.1136/annrheumdis-2012-202911. Epub 2013 Mar 21. Ann Rheum Dis. 2014. PMID: 23520035
RESULTS: 71% of patients with full baseline work ability still had full work ability after 3 years compared with 36% (p<0.001) and 18% (p<0.001) of those with partial and no work ability at baseline, respectively. Elevated baseline levels of HAQ and DAS28, hig …
RESULTS: 71% of patients with full baseline work ability still had full work ability after 3 years compared with 36% (p<0.001) and …
Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis.
Kapetanovic MC, Kristensen LE, Saxne T, Aktas T, Mörner A, Geborek P. Kapetanovic MC, et al. Among authors: geborek p. Arthritis Res Ther. 2014 Jan 2;16(1):R2. doi: 10.1186/ar4427. Arthritis Res Ther. 2014. PMID: 24383620 Free PMC article.
RA patients on rituximab had significantly lower (P < 0.001) and SpA on anti-TNF monotherapy significantly better response rates compared to other treatment groups (P 0.001 to 0.033). Higher age (P < 0.001) predicted impaired immune response. Antibody t …
RA patients on rituximab had significantly lower (P < 0.001) and SpA on anti-TNF monotherapy significantly better response rates c …
Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis.
Crnkic Kapetanovic M, Saxne T, Jönsson G, Truedsson L, Geborek P. Crnkic Kapetanovic M, et al. Among authors: geborek p. Arthritis Res Ther. 2013 Oct 30;15(5):R171. doi: 10.1186/ar4358. Arthritis Res Ther. 2013. PMID: 24286269 Free PMC article. Clinical Trial.
Persistence of antibody response 1.5 years after vaccination using 7-valent pneumococcal conjugate vaccine in patients with arthritis treated with different antirheumatic drugs.
Crnkic Kapetanovic M, Saxne T, Truedsson L, Geborek P. Crnkic Kapetanovic M, et al. Among authors: geborek p. Arthritis Res Ther. 2013 Jan 4;15(1):R1. doi: 10.1186/ar4127. Arthritis Res Ther. 2013. PMID: 23286772 Free PMC article. Clinical Trial.
Compared with postvaccination levels at 1.5 years, GMLs for each serotype were significantly lower in all groups (P between 0.035 and <0.001; paired-sample t test), as were the proportions of patients with protective antibody levels for both serotypes (P<0.001 …
Compared with postvaccination levels at 1.5 years, GMLs for each serotype were significantly lower in all groups (P between 0.035 and …
Is swollen to tender joint count ratio a new and useful clinical marker for biologic drug response in rheumatoid arthritis? Results from a Swedish cohort.
Kristensen LE, Bliddal H, Christensen R, Karlsson JA, Gülfe A, Saxne T, Geborek P. Kristensen LE, et al. Among authors: geborek p. Arthritis Care Res (Hoboken). 2014 Feb;66(2):173-9. doi: 10.1002/acr.22107. Arthritis Care Res (Hoboken). 2014. PMID: 23982986
Logistic regression analysis consistently showed that moderate STR, high STR, not using prednisolone, high baseline Disease Activity Score in 28 joints, and low baseline Health Assessment Questionnaire scores were significantly associated with favorable ACR50 response with odds r …
Logistic regression analysis consistently showed that moderate STR, high STR, not using prednisolone, high baseline Disease Activity Score i …
EQ-5D utility, response and drug survival in rheumatoid arthritis patients on biologic monotherapy: A prospective observational study of patients registered in the south Swedish SSATG registry.
Jørgensen TS, Turesson C, Kapetanovic M, Englund M, Turkiewicz A, Christensen R, Bliddal H, Geborek P, Kristensen LE. Jørgensen TS, et al. Among authors: geborek p. PLoS One. 2017 Feb 2;12(2):e0169946. doi: 10.1371/journal.pone.0169946. eCollection 2017. PLoS One. 2017. PMID: 28151971 Free PMC article.
Although the changes were numerically different, no distinct pattern favored any particular bDMARD for EQ-5D-3L (p = 0.49) or other clinical outcomes. ...Drug survival rates were statistically significantly different between bDMARDs (p = 0.01), with the highest rate …
Although the changes were numerically different, no distinct pattern favored any particular bDMARD for EQ-5D-3L (p = 0.49) or other c …
Comparison of non-radiographic axial spondyloarthritis and ankylosing spondylitis patients--baseline characteristics, treatment adherence, and development of clinical variables during three years of anti-TNF therapy in clinical practice.
Wallman JK, Kapetanovic MC, Petersson IF, Geborek P, Kristensen LE. Wallman JK, et al. Among authors: geborek p. Arthritis Res Ther. 2015 Dec 24;17:378. doi: 10.1186/s13075-015-0897-6. Arthritis Res Ther. 2015. PMID: 26703005 Free PMC article.
Apart from CRP, which remained lower in the nr-axSpA group throughout follow-up (p = 0.004), no between-group differences were detected regarding clinical developments (p >0.1 for all comparisons) or anti-TNF adherence (hazard ratio: 1.1 (95% CI 0.7 to 1.8) for t …
Apart from CRP, which remained lower in the nr-axSpA group throughout follow-up (p = 0.004), no between-group differences were detect …
The association between antibody levels before and after 7-valent pneumococcal conjugate vaccine immunization and subsequent pneumococcal infection in chronic arthritis patients.
Nagel J, Geborek P, Saxne T, Jönsson G, Englund M, Petersson IF, Nilsson JÅ, Truedsson L, Kapetanovic MC. Nagel J, et al. Among authors: geborek p. Arthritis Res Ther. 2015 May 19;17(1):124. doi: 10.1186/s13075-015-0636-z. Arthritis Res Ther. 2015. PMID: 25986458 Free PMC article. Clinical Trial.
Patients with serious infections after vaccination had significantly lower post-vaccination antibody titres for both 6B (P=0.04) and 23 F (P=0.04). ...
Patients with serious infections after vaccination had significantly lower post-vaccination antibody titres for both 6B (P=0.04) and …
154 results
Jump to page
Feedback